Blueprint Medicines Corp (BPMC) Annual Income Statement (USD)
BPMC Quarterly Financials (USD)
Frequently Asked Questions About Blueprint Medicines Corp (BPMC) Stock
Blueprint Medicines Corp's (BPMC) last reported annual revenue was USD 249.38 Million.
Blueprint Medicines Corp's (BPMC) annual revenue growth rate based on the revenue reported in the past 5 years is : 41.14%
Blueprint Medicines Corp's(BPMC) is not profitable as of its last reported annual financials.
The net profit margin for Blueprint Medicines Corp's(BPMC) from its laster reported year is -203.30%
The return on equity (ROE) for Blueprint Medicines Corp's(BPMC) from its last reported annual financials is : -157.14%
The return on assets (ROA) for Blueprint Medicines Corp's(BPMC) from its last reported annual financials is : -25.34%
The return on invested capital (ROIC) for Blueprint Medicines Corp's(BPMC) from its last reported annual financials is : -67.85%
The Debt to Equity ratio for Blueprint Medicines Corp's(BPMC) from its last reported annual financials is : 159.66%
The dividend yield for Blueprint Medicines Corp's(BPMC) from its laster reported year is 0.00%
Blueprint Medicines Corp's(BPMC) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BPMC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
